Streetbeat News

Regulatory

CYBN

Cybin Inc. (NYSE:CYBN) has initiated preparations for good manufacturing practices (GMP) production of a capsule formulation of CYB003, its proprietary deuterated psilocybin analog in development for the potential treatment of Major Depressive Disorder (MDD). The company plans to ship CYB003 capsules to clinical sites in Q1 2024. The company has also been granted a U.S. patent for the composition of matter claims and treatment methods in support of the CYB003 program until 2041.

Portfolio Pulse from Happy Mohamed

August 17, 2023 | 12:04 pm

IDAI

Trust Stamp has received a new patent issuance for Patent #11,729,158 titled 'Systems and Methods For Identity Authentication Via Third Party Accounts'.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:03 pm

NVCT

The FDA has granted Orphan Drug Designation to Nuvectis Pharma's NXP800 for the treatment of Cholangiocarcinoma. This designation provides certain benefits including tax credits, market exclusivity, and waiver of certain fees.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:02 pm

RCRT

Shares of Recruiter.Com (RCRT) have been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 11:56 am

ACI

KR

Officials from seven U.S. states have written to the Federal Trade Commission (FTC) opposing Kroger Company's (NYSE:KR) proposed $24.6 billion acquisition of Albertsons Companies Inc (NYSE:ACI). They argue that the merger would give Kroger/Albertsons nearly a quarter of the U.S. food retail market. The FTC is currently conducting an antitrust probe into the deal.

Portfolio Pulse from Shivani Kumaresan

August 17, 2023 | 10:46 am

FXI

SPY

China and the U.S. are in discussions regarding the arrangements for U.S. Commerce Secretary Gina Raimondo's visit to China. The news was reported by Reuters but no further details were provided.

Portfolio Pulse from Charles Gross

August 17, 2023 | 10:17 am

FXI

SPY

China's Commerce Ministry is making a comprehensive assessment of the U.S. executive order restricting foreign investment and will adopt necessary measures based on the assessment results.

Portfolio Pulse from Charles Gross

August 17, 2023 | 10:14 am

F

FXI

GM

SPY

STLA

TSLA

US imports of auto parts are under scrutiny due to a law on Chinese forced labor. This could potentially impact several US-listed companies that rely on these imports for their operations.

Portfolio Pulse from Charles Gross

August 17, 2023 | 10:12 am

FXI

China's Central Bank has announced its plans to fend off systemic financial risks, adjust and optimize property policies in a timely manner, keep prices stable, and promote consumption and investment through finance. This could impact the iShares China Large-Cap ETF (FXI).

Portfolio Pulse from Charles Gross

August 17, 2023 | 9:58 am

FXI

China's Central Bank has announced that it will maintain a prudent monetary policy that will be precise and forceful. It also plans to keep liquidity reasonably ample and the Yuan exchange rate basically stable.

Portfolio Pulse from Charles Gross

August 17, 2023 | 9:56 am